ASO Visual Abstract: Can We Forego Sentinel Lymph Node Biopsy in Women &#8805;50 Years of Age with Early-Stage Hormone Receptor-Positive HER2-Negative Special Histologic Subtype Breast Cancer?

Knape, Nicole; Park, Ji-Hye; Agala, Chris B; Spanheimer, Philip; Morrow, Monica; Downs-Canner, Stephanie; Baldwin, Xavier L

ASO Visual Abstract: Can We Forego Sentinel Lymph Node Biopsy in Women ≥50 Years of Age with Early-Stage Hormone Receptor-Positive HER2-Negative Special Histologic Subtype Breast Cancer?

Knape, Nicole; Park, Ji-Hye; Agala, Chris B; Spanheimer, Philip; Morrow, Monica; Downs-Canner, Stephanie; Baldwin, Xavier L.

Afiliação

Knape N; University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Park JH; Gillings School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Agala CB; Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Spanheimer P; Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Morrow M; Breast Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Downs-Canner S; Breast Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. downscas@mskcc.org.
Baldwin XL; Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Xavier.baldwin@unchealth.Unc.edu.

Ann Surg Oncol ; 30(2): 1053, 2023 Feb.

Article em En | MEDLINE | ID: mdl-36331657

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Ann Surg Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google